Diphtheria, Tetanus Toxoids and Acellular Pertussis Adsorbed, Hepatitis B and Inactivated Poliovirus Vaccine Articles

GlaxoSmithKline to refocus some research and seek efficiencies, despite posting huge 4th-qtr 2009 profits rise; applause from Science Minister

5 February 2010

GlaxoSmithKline beats forecasts with 3rd quarter2009 profits leaping 34%, despite generic competition

28 October 2009

GSK's 2008 sales grow 7%, but EPS falls on restructuring; confirms more jobs to go

16 February 2009

GlaxoSmithKline sees flattish 2nd-qtr results, but sales helped by Advair

30 July 2007

GSK posts solid results for 1st-qtr 2007 with a 14% EPS rise despite US generic pressure

30 April 2007

US sales boost GlaxoSmithKline's 2006 results, with global pharma up 9%

19 February 2007

GlaxoSmithKline sees 2nd-qtr net leap 14% on strong, 11%, sales growth

31 July 2006

CDC votes to add GSK's Pediarix to vaccination schedule

10 March 2003

Showing 1-8 of 8 articles

Go to beginningPrevious
  • 1
NextGo to end